Fibrobiologics Inc (FBLG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,402 | -9,624 | -4,966 | -11,161 | -8,062 |
| Depreciation Amortization | 598 | 367 | 161 | 573 | 420 |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | -141 | N/A |
| Other Working Capital | -1,976 | -2,034 | -1,555 | 2,422 | 838 |
| Other Operating Activity | 3,549 | 2,032 | 1,085 | -3,594 | -2,024 |
| Operating Cash Flow | $-13,231 | $-9,259 | $-5,275 | $-11,901 | $-8,828 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -262 | -256 | -43 | -184 | -85 |
| Investing Cash Flow | $-262 | $-256 | $-43 | $-184 | $-85 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 4,375 | 4,375 | N/A | 9,974 | 574 |
| Common Stock Issued | N/A | N/A | N/A | 7,507 | 7,462 |
| Other Financing Activity | 0 | 0 | 0 | -574 | -459 |
| Financing Cash Flow | $4,375 | $4,375 | $N/A | $16,907 | $7,577 |
| Beginning Cash Position | 13,985 | 13,985 | 13,985 | 9,163 | 9,163 |
| End Cash Position | 4,867 | 8,845 | 8,667 | 13,985 | 7,827 |
| Net Cash Flow | $-9,118 | $-5,140 | $-5,318 | $4,822 | $-1,336 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,231 | -9,259 | -5,275 | -11,901 | -8,828 |
| Capital Expenditure | -262 | -256 | -43 | -184 | -85 |
| Free Cash Flow | -13,493 | -9,515 | -5,318 | -12,085 | -8,913 |